Fixed-dose combinations for emerging treatment of pain

Robert B. Raffa, Ronald J. Tallarida, Robert Taylor, Joseph V. Pergolizzi

Research output: Contribution to journalArticle

Abstract

Introduction: Pain is a large and growing medical need that is not currently being fully met, primarily due to the shortcomings of existing analgesics (insufficient efficacy or limiting side-effects). Better outcomes might be achieved using a combination of analgesics. The ratio of the combinations matters and should therefore be evaluated using rigorous quantitative and well-documented analysis. Areas covered: Advances have been made in understanding the normal physiology of pain processing, including the pathways and neurotransmitters involved. Insight has also been gained about physiological processes that can lead to different 'types' of pain and the transition from acute to chronic pain conditions. This 'multimechanistic' nature of most pains is better matched using a 'multimechanistic' rather than 'monomechanistic' analgesic approach. Such an approach and the experimental design and data analysis to assess optimal combinations - is described and discussed. Expert opinion: There are sound pharmacologic, as well as practical, reasons for using combinations of drugs to treat pain. Compared with single agents, they offer a potential better match to the underlying pain physiology and thus greater efficacy or reduced side effects. The optimal efficacy and side-effect ratio must be determined in a scientifically rigorous manner.

Original languageEnglish (US)
Pages (from-to)1261-1270
Number of pages10
JournalExpert Opinion on Pharmacotherapy
Volume13
Issue number9
DOIs
StatePublished - Jun 2012

Fingerprint

Pain
Analgesics
Therapeutics
Physiological Phenomena
Expert Testimony
Drug Combinations
Chronic Pain
Neurotransmitter Agents
Research Design

Keywords

  • Analgesic
  • Combination therapy
  • Fixed-dose
  • Isobole
  • Pain

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology

Cite this

Raffa, R. B., Tallarida, R. J., Taylor, R., & Pergolizzi, J. V. (2012). Fixed-dose combinations for emerging treatment of pain. Expert Opinion on Pharmacotherapy, 13(9), 1261-1270. https://doi.org/10.1517/14656566.2012.668531

Fixed-dose combinations for emerging treatment of pain. / Raffa, Robert B.; Tallarida, Ronald J.; Taylor, Robert; Pergolizzi, Joseph V.

In: Expert Opinion on Pharmacotherapy, Vol. 13, No. 9, 06.2012, p. 1261-1270.

Research output: Contribution to journalArticle

Raffa, RB, Tallarida, RJ, Taylor, R & Pergolizzi, JV 2012, 'Fixed-dose combinations for emerging treatment of pain', Expert Opinion on Pharmacotherapy, vol. 13, no. 9, pp. 1261-1270. https://doi.org/10.1517/14656566.2012.668531
Raffa, Robert B. ; Tallarida, Ronald J. ; Taylor, Robert ; Pergolizzi, Joseph V. / Fixed-dose combinations for emerging treatment of pain. In: Expert Opinion on Pharmacotherapy. 2012 ; Vol. 13, No. 9. pp. 1261-1270.
@article{e33773c4556d46bb9b5cc3269bb98cd1,
title = "Fixed-dose combinations for emerging treatment of pain",
abstract = "Introduction: Pain is a large and growing medical need that is not currently being fully met, primarily due to the shortcomings of existing analgesics (insufficient efficacy or limiting side-effects). Better outcomes might be achieved using a combination of analgesics. The ratio of the combinations matters and should therefore be evaluated using rigorous quantitative and well-documented analysis. Areas covered: Advances have been made in understanding the normal physiology of pain processing, including the pathways and neurotransmitters involved. Insight has also been gained about physiological processes that can lead to different 'types' of pain and the transition from acute to chronic pain conditions. This 'multimechanistic' nature of most pains is better matched using a 'multimechanistic' rather than 'monomechanistic' analgesic approach. Such an approach and the experimental design and data analysis to assess optimal combinations - is described and discussed. Expert opinion: There are sound pharmacologic, as well as practical, reasons for using combinations of drugs to treat pain. Compared with single agents, they offer a potential better match to the underlying pain physiology and thus greater efficacy or reduced side effects. The optimal efficacy and side-effect ratio must be determined in a scientifically rigorous manner.",
keywords = "Analgesic, Combination therapy, Fixed-dose, Isobole, Pain",
author = "Raffa, {Robert B.} and Tallarida, {Ronald J.} and Robert Taylor and Pergolizzi, {Joseph V.}",
year = "2012",
month = "6",
doi = "10.1517/14656566.2012.668531",
language = "English (US)",
volume = "13",
pages = "1261--1270",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "Informa Healthcare",
number = "9",

}

TY - JOUR

T1 - Fixed-dose combinations for emerging treatment of pain

AU - Raffa, Robert B.

AU - Tallarida, Ronald J.

AU - Taylor, Robert

AU - Pergolizzi, Joseph V.

PY - 2012/6

Y1 - 2012/6

N2 - Introduction: Pain is a large and growing medical need that is not currently being fully met, primarily due to the shortcomings of existing analgesics (insufficient efficacy or limiting side-effects). Better outcomes might be achieved using a combination of analgesics. The ratio of the combinations matters and should therefore be evaluated using rigorous quantitative and well-documented analysis. Areas covered: Advances have been made in understanding the normal physiology of pain processing, including the pathways and neurotransmitters involved. Insight has also been gained about physiological processes that can lead to different 'types' of pain and the transition from acute to chronic pain conditions. This 'multimechanistic' nature of most pains is better matched using a 'multimechanistic' rather than 'monomechanistic' analgesic approach. Such an approach and the experimental design and data analysis to assess optimal combinations - is described and discussed. Expert opinion: There are sound pharmacologic, as well as practical, reasons for using combinations of drugs to treat pain. Compared with single agents, they offer a potential better match to the underlying pain physiology and thus greater efficacy or reduced side effects. The optimal efficacy and side-effect ratio must be determined in a scientifically rigorous manner.

AB - Introduction: Pain is a large and growing medical need that is not currently being fully met, primarily due to the shortcomings of existing analgesics (insufficient efficacy or limiting side-effects). Better outcomes might be achieved using a combination of analgesics. The ratio of the combinations matters and should therefore be evaluated using rigorous quantitative and well-documented analysis. Areas covered: Advances have been made in understanding the normal physiology of pain processing, including the pathways and neurotransmitters involved. Insight has also been gained about physiological processes that can lead to different 'types' of pain and the transition from acute to chronic pain conditions. This 'multimechanistic' nature of most pains is better matched using a 'multimechanistic' rather than 'monomechanistic' analgesic approach. Such an approach and the experimental design and data analysis to assess optimal combinations - is described and discussed. Expert opinion: There are sound pharmacologic, as well as practical, reasons for using combinations of drugs to treat pain. Compared with single agents, they offer a potential better match to the underlying pain physiology and thus greater efficacy or reduced side effects. The optimal efficacy and side-effect ratio must be determined in a scientifically rigorous manner.

KW - Analgesic

KW - Combination therapy

KW - Fixed-dose

KW - Isobole

KW - Pain

UR - http://www.scopus.com/inward/record.url?scp=84861401630&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861401630&partnerID=8YFLogxK

U2 - 10.1517/14656566.2012.668531

DO - 10.1517/14656566.2012.668531

M3 - Article

VL - 13

SP - 1261

EP - 1270

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

SN - 1465-6566

IS - 9

ER -